Viridian Therapeutics, Inc. has grown revenue 264% a year over three years and 94% a year over five. Revenue growth, 3-year annual rate: +264% (Biotechnology median +17%). Revenue growth, 5-year rate: +94%, growth has picked up over the last three years. Years of annual history on file: 13, FY2013 to FY2025, as filed.

VRDNViridian Therapeutics, Inc.

Healthcare

$18.67-3.9% 1Y

$18.67

$13.3052 weeks$33.78

Is it growing?

Good

Growing: revenue growing +23220% year on year and operating margin widening (+67846.5 points).

2 good, 1 without data

Revenue trend+23220% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +94% a year.

Margin direction+67846.5 points operating

Trailing-twelve-month operating margin, -54974.6% now against -122821.0% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is VRDN growing?

Viridian Therapeutics, Inc. has grown revenue 264% a year over three years and 94% a year over five.

+264%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +94%
Revenue growth, 5-year rate · +264% over three · growth has picked up over the last three years
Years of annual history on file: 13
Years of annual history on file · FY2013 to FY2025, as filed

Details›